Skip to main content

Pleomorphic Hyalinizing Angiectatic Tumor

  • Chapter
  • First Online:
  • 33 Accesses

Abstract

Pleomorphic hyalinizing angiectatic tumor of soft parts is a benign soft tissue tumor of uncertain differentiation. It is considered related to hemosiderotic fibrolipomatous tumor.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Notes

  1. 1.

    TGFBR3-MGEA5 fusion gene: TGFBR3 (transforming growth factor beta receptor 3) encodes a receptor which is a membrane proteoglycan that often functions as a co-receptor with other TGF-beta receptor superfamily members. MGEA5 (also known as OGA, O-GlcNAcase): the modification of cytoplasmic and nuclear proteins by O-linked N-acetylglucosamine (O-GlcNAc) addition and removal on serine and threonine residues is catalyzed by OGT (which adds O-GlcNAc) and MGEA5, a glycosidase that removes O-GlcNAc modifications.

Suggested Readings

  • Fletcher et al (2020) WHO classification of tumours of soft tissue and bone, 5th edn

    Google Scholar 

  • Liu et al (2019) The t(1;10)(p22;q24) TGFBR3/MGEA5 translocation in pleomorphic hyalinizing angiectatic tumor, myxoinflammatory fibroblastic sarcoma, and hemosiderotic fibrolipomatous tumor. Arch Pathol Lab Med 143(2):212–221

    Article  CAS  Google Scholar 

  • Rougemont et al (2019) Targeted RNA-sequencing identifies FBXW4 instead of MGEA5 as fusion partner of TGFBR3 in pleomorphic hyalinizing angiectatic tumor. Virchows Arch 475(2):251–254

    Article  CAS  Google Scholar 

  • Rush et al (2018) Treatment modalities and outcomes of pleomorphic hyalinizing angiectatic tumor: a systematic review of the literature. Musculoskelet Surg 102(3):213–221

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simone Mocellin .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mocellin, S. (2021). Pleomorphic Hyalinizing Angiectatic Tumor. In: Soft Tissue Tumors . Springer, Cham. https://doi.org/10.1007/978-3-030-58710-9_204

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-58710-9_204

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-58709-3

  • Online ISBN: 978-3-030-58710-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics